DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bravelle (Urofollitropin) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Bravelle (Urofollitropin) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (1)

Reports by Reaction Type

Abortion Spontaneous (1)Maternal Exposure During Pregnancy (1)

Possible Bravelle side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-19

Patient: female, weighing 79.4 kg (174.6 pounds)

Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous

Drug(s) suspected as cause:
Bravelle
    Dosage: (150 -0225 iu everyday (qd))
    Indication: in Vitro Fertilisation
    Start date: 2009-11-01
    End date: 2009-11-23

Menotropins
    Indication: in Vitro Fertilisation
    Start date: 2009-11-01
    End date: 2009-11-23

Other drugs received by patient: Prenatal Vitamins / 01549301 /; Progesterone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014